David L. Lucchino - 18 Jan 2022 Form 4 Insider Report for Frequency Therapeutics, Inc. (KRRO)

Role: President and CEO, Director
Signature: /s/ James P. Abely, Attorney-in-Fact for David L. Lucchino
Issuer symbol: KRRO
Transactions as of: 18 Jan 2022
Net transactions value: +$4,212
Form type: 4
Filing time: 20 Jan 2022, 07:33:43 UTC
Previous filing: 21 Dec 2021
Next filing: 18 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FREQ	Common Stock	Options Exercise	$4,212	+6,905	+1.5%	$0.6100	470,111	18 Jan 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	FREQ	Stock Option	Options Exercise	$0	-6,905	-100%	$0.000000^*	0	18 Jan 2022	Common Stock	6,905	$0.6100	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option vests and becomes exercisable in equal monthly installments over a four year period commencing on February 1, 2018, and will be fully vested and exercisable on January 1, 2022.